Sign in

CIK 0001595248

  • Non-accelerated filer
  • Smaller reporting company

Genprex, Inc.

Sign in to watch
Ticker
GNPX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TX
Entity type
Operating
EIN
900772347
Phone
+1 512-537-7997
Business address
3300 BEE CAVE ROAD SUITE 650-227, AUSTIN, TX, 78746
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-02-18 Varner John Rodney Chairman, President and CEO Shares withheld for taxes −2,642 $4.40 $12K 26,352
2023-04-21 Varner John Rodney Chairman, President and CEO Purchase +19,000 $1.06 $20K 20,800
2023-02-18 Varner John Rodney President & CEO Grant or award +625,000 1,159,735
2022-02-04 Varner John Rodney President & CEO Grant or award · Stock Option (right to buy) +1,062,250 1,062,250
2021-03-19 Varner John Rodney President & CEO Grant or award · Stock Option (right to buy) +460,000 460,000
2020-08-21 Varner John Rodney President & CEO Grant or award · Stock Option (right to buy) +530,000 530,000
2019-09-05 Varner John Rodney Chief Executive Officer Purchase +1,800 $0.89 $2K 1,800
2019-01-25 Varner John Rodney Chief Executive Officer Grant or award · Stock Option (Right to Buy) +615,384 615,384
2018-11-02 Varner John Rodney Chief Executive Officer Grant or award · Stock Option (Right to Buy) +551,284 551,284
2018-03-29 Varner John Rodney Chief Executive Officer Purchase +10,000 $5.00 $50K 544,735

Page 1 of 1 · 10 trades